These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Characterization of adenosine receptors in human kidney proximal tubule (HK-2) cells. Lee HT; Emala CW Exp Nephrol; 2002; 10(5-6):383-92. PubMed ID: 12381923 [TBL] [Abstract][Full Text] [Related]
8. A(3) adenosine receptor ligands: history and perspectives. Baraldi PG; Cacciari B; Romagnoli R; Merighi S; Varani K; Borea PA; Spalluto G Med Res Rev; 2000 Mar; 20(2):103-28. PubMed ID: 10723024 [TBL] [Abstract][Full Text] [Related]
9. A1 adenosine receptors and their ligands: overview and recent developments. Müller CE Farmaco; 2001; 56(1-2):77-80. PubMed ID: 11347971 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of [4-O-methyl-(11)C]KW-6002 as a potential PET ligand for mapping central adenosine A(2A) receptors in rats. Hirani E; Gillies J; Karasawa A; Shimada J; Kase H; Opacka-Juffry J; Osman S; Luthra SK; Hume SP; Brooks DJ Synapse; 2001 Dec; 42(3):164-76. PubMed ID: 11746713 [TBL] [Abstract][Full Text] [Related]
11. Positron emission tomography: the conceptual idea using a multidisciplinary approach. Paans AM; van Waarde A; Elsinga PH; Willemsen AT; Vaalburg W Methods; 2002 Jul; 27(3):195-207. PubMed ID: 12183107 [TBL] [Abstract][Full Text] [Related]
12. Medicinal Chemistry and Therapeutic Potential of Agonists, Antagonists and Allosteric Modulators of A1 Adenosine Receptor: Current Status and Perspectives. Deb PK; Deka S; Borah P; Abed SN; Klotz KN Curr Pharm Des; 2019; 25(25):2697-2715. PubMed ID: 31333094 [TBL] [Abstract][Full Text] [Related]
13. Recent progress in the development of adenosine receptor ligands as antiinflammatory drugs. Akkari R; Burbiel JC; Hockemeyer J; Müller CE Curr Top Med Chem; 2006; 6(13):1375-99. PubMed ID: 16918456 [TBL] [Abstract][Full Text] [Related]
14. Adenosine receptors and asthma in humans. Wilson CN Br J Pharmacol; 2008 Oct; 155(4):475-86. PubMed ID: 18852693 [TBL] [Abstract][Full Text] [Related]
15. Adenosine receptor PET imaging in human brain. Mishina M; Ishiwata K Int Rev Neurobiol; 2014; 119():51-69. PubMed ID: 25175960 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of 18F-CPFPX, a novel adenosine A1 receptor ligand: in vitro autoradiography and high-resolution small animal PET. Bauer A; Holschbach MH; Cremer M; Weber S; Boy C; Shah NJ; Olsson RA; Halling H; Coenen HH; Zilles K J Nucl Med; 2003 Oct; 44(10):1682-9. PubMed ID: 14530487 [TBL] [Abstract][Full Text] [Related]
18. Positron emission tomography in drug development and drug evaluation. Paans AM; Vaalburg W Curr Pharm Des; 2000 Nov; 6(16):1583-91. PubMed ID: 10974154 [TBL] [Abstract][Full Text] [Related]
19. Adenosine receptor ligands and PET imaging of the CNS. Bauer A; Ishiwata K Handb Exp Pharmacol; 2009; (193):617-42. PubMed ID: 19639295 [TBL] [Abstract][Full Text] [Related]
20. Design, radiosynthesis, and biodistribution of a new potent and selective ligand for in vivo imaging of the adenosine A(2A) receptor system using positron emission tomography. Todde S; Moresco RM; Simonelli P; Baraldi PG; Cacciari B; Spalluto G; Varani K; Monopoli A; Matarrese M; Carpinelli A; Magni F; Kienle MG; Fazio F J Med Chem; 2000 Nov; 43(23):4359-62. PubMed ID: 11087559 [No Abstract] [Full Text] [Related] [Next] [New Search]